| typ : |
noviny |
|
| výzkumné týmy : |
Callaghan - School of Pharmacy and Medical Sciences |
| Autor : |
Sharley NA, Yu AMC, Williams DB. |
| titul : |
Stability of mixtures formulated from warfarin tablets or powder. |
| Référence : |
J Pharm Pract and Res ; 37: 95-97. 2007 |
|
| Úroveň důkazu : |
|
| Fyzikální stabilita : |
|
| chemická stabilita : |
|
| jiné metody : |
|
| Komentáře : |
|
Seznamy
 Warfarin sodium
|
 |
 |
 |
 |
300 mg
Coumadin® |
| sodík fosfát |
3000 mg |
| tragant |
4% 60 ml |
| Sorbitol sirup |
5% 75 ml |
| methylparabenu |
240 mg |
| propylparaben |
60 mg |
| propylenglykol |
3 ml |
| destilovaná voda |
>> 300 ml |
|
20-24°C |
 |
| 28 |
 |
|
|
|
|
|
300 mg
Marevan® |
| sodík fosfát |
3000 mg |
| tragant |
4% 60 ml |
| Sorbitol sirup |
5% 75 ml |
| methylparabenu |
240 mg |
| propylparaben |
60 mg |
| propylenglykol |
3 ml |
| destilovaná voda |
>> 300 ml |
|
20-24°C |
|
| 28 |
|
|
|
|
|
Warfarin sodium clathrate
|
|
|
|
 |
324.3 mg
Warfarin sodium clathrate |
| sodík fosfát |
3000 mg |
| methylparabenu |
240 mg |
| propylparaben |
60 mg |
| propylenglykol |
3 ml |
| destilovaná voda |
>> 300 ml |
|
20-24°C |
|
| 28 |
|
|
|
|
|
